ArticleCancers2019

Preferential Response of Basal-Like Head and Neck Squamous Cell Carcinoma Cell Lines to EGFR-Targeted Therapy Depending on

Sylvie Job et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.